Rohan Basu, Joshua Davis, Mackenzie Madison, Alexa Hughes, John Maijub, Raghu Motaganahalli, Andres Fajardo
{"title":"Salvage of Failing Abdominal Aortic Aneurysm Repairs with Fenestrated Endovascular Aortic Repair","authors":"Rohan Basu, Joshua Davis, Mackenzie Madison, Alexa Hughes, John Maijub, Raghu Motaganahalli, Andres Fajardo","doi":"10.1016/j.avsg.2025.08.015","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Fenestrated endovascular aortic repair (FEVAR) can be used for salvage of failing abdominal aortic aneurysm (AAA) repairs. We describe our experience with the commercially available Zenith fenestrated (ZFEN) platform to salvage failing AAA repairs.</div></div><div><h3>Methods</h3><div>This is a retrospective review of all FEVARs performed from January 2012 until August 2019 at a tertiary academic medical center. The study compared primary FEVAR against reoperative FEVARs (RFEVAR) done for salvage of prior infrarenal aneurysm repairs with 60 months of follow-up. The primary outcome was technical success. Secondary outcomes included mortality, reintervention, and complications.</div></div><div><h3>Results</h3><div>There were 153 patients meeting inclusion criteria, with 133 primary repairs and 20 RFEVARs. Indications for repair included proximal disease progression (55%) and type IA endoleak (45%). Primary FEVARs were associated with decreased case complexity, with shorter operative time (217.6 vs. 265.6 minutes, <em>P</em> = 0.018) and number of visceral arteries stented (2.2 vs. 2.6, <em>P</em> = 0.021). Technical success was 97.7% in the primary FEVAR group, versus 95.0% in the RFEVAR group (<em>P</em> = 0.43). At 60 months, estimated survival and freedom from reintervention did not differ between groups and were 68.8% (<em>P</em> = 0.38) and 76.0% (<em>P</em> = 0.80), respectively, in the RFEVAR group.</div></div><div><h3>Conclusion</h3><div>RFEVAR using ZFEN is effective to salvage failing AAA repairs, with 60-month outcomes comparable to primary repair of AAA using FEVAR. RFEVAR is attractive over traditional open approaches as it avoids significant morbidity. These results support the long-term efficacy of ZFEN to salvage failing aortic repairs.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"121 ","pages":"Pages 446-455"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0890509625005576","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Fenestrated endovascular aortic repair (FEVAR) can be used for salvage of failing abdominal aortic aneurysm (AAA) repairs. We describe our experience with the commercially available Zenith fenestrated (ZFEN) platform to salvage failing AAA repairs.
Methods
This is a retrospective review of all FEVARs performed from January 2012 until August 2019 at a tertiary academic medical center. The study compared primary FEVAR against reoperative FEVARs (RFEVAR) done for salvage of prior infrarenal aneurysm repairs with 60 months of follow-up. The primary outcome was technical success. Secondary outcomes included mortality, reintervention, and complications.
Results
There were 153 patients meeting inclusion criteria, with 133 primary repairs and 20 RFEVARs. Indications for repair included proximal disease progression (55%) and type IA endoleak (45%). Primary FEVARs were associated with decreased case complexity, with shorter operative time (217.6 vs. 265.6 minutes, P = 0.018) and number of visceral arteries stented (2.2 vs. 2.6, P = 0.021). Technical success was 97.7% in the primary FEVAR group, versus 95.0% in the RFEVAR group (P = 0.43). At 60 months, estimated survival and freedom from reintervention did not differ between groups and were 68.8% (P = 0.38) and 76.0% (P = 0.80), respectively, in the RFEVAR group.
Conclusion
RFEVAR using ZFEN is effective to salvage failing AAA repairs, with 60-month outcomes comparable to primary repair of AAA using FEVAR. RFEVAR is attractive over traditional open approaches as it avoids significant morbidity. These results support the long-term efficacy of ZFEN to salvage failing aortic repairs.
期刊介绍:
Annals of Vascular Surgery, published eight times a year, invites original manuscripts reporting clinical and experimental work in vascular surgery for peer review. Articles may be submitted for the following sections of the journal:
Clinical Research (reports of clinical series, new drug or medical device trials)
Basic Science Research (new investigations, experimental work)
Case Reports (reports on a limited series of patients)
General Reviews (scholarly review of the existing literature on a relevant topic)
Developments in Endovascular and Endoscopic Surgery
Selected Techniques (technical maneuvers)
Historical Notes (interesting vignettes from the early days of vascular surgery)
Editorials/Correspondence